INNATE PHARMA SA (IDD.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:IDD - FR0010331421 - Common Stock
1.654 EUR
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to IDD.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.58. This target is 237.28% above the current price.
IDD.DE was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about IDD.DE.
In the previous month the buy percentage consensus was at a similar level.
IDD.DE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
INNATE PHARMA SA / IDD.DE FAQ
Can you provide the average price target for INNATE PHARMA SA stock?
9 analysts have analysed IDD.DE and the average price target is 5.58 EUR. This implies a price increase of 237.28% is expected in the next year compared to the current price of 1.654.
What is the consensus rating for IDD stock?
The consensus rating for INNATE PHARMA SA (IDD.DE) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed INNATE PHARMA SA (IDD.DE)?
The number of analysts covering INNATE PHARMA SA (IDD.DE) is 9.